Instil Bio earnings were -$78.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TIL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$28.2M, up 137.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TIL reported annual earnings of -$74.1M, with -52.5% growth.
On TIL's earnings call on Invalid Date, Instil Bio (NASDAQ: TIL) reported Q1 2025 earnings per share (EPS) of -$4.32, up 15.51% year over year. Total TIL earnings for the quarter were -$28.20 million. In the same quarter last year, Instil Bio's earnings per share (EPS) was -$3.74.
As of the last Instil Bio earnings report, Instil Bio is currently losing money. Instil Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$78.03 million, a 36.72% decrease year over year.
What was TIL's earnings growth in the past year?
As of Instil Bio's earnings date in Invalid Date, Instil Bio's earnings has grown year over year. TIL earnings in the past year totalled -$78.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.